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ABSTRACT  
During development of pharmaceuticals, it is essential to as early as possible identify and 
preferably avoid formation of reactive metabolites and intermediates. Reactive metabolites 
may represent obstacles in the development and use of drugs, due to their potential toxicity. 
The formation of reactive metabolites often involves oxidation reactions and the cytochrome 
P450 (CYP) enzymes are the most important enzymes catalyzing oxidative phase I drug 
metabolism. The present studies were initiated with the aim to chemically mimic phase I drug 
oxidations, using electrochemistry for characterization and identification of reactive drug 
metabolites and to avoid metabolic activation by altering the chemical structure of the parent 
drug.  
Three complementary chemical systems were evaluated for their abilities to mimic CYP-
catalyzed oxidations. All relevant oxidative reactions were mimicked by at least one of the 
three systems. The oxidative metabolism of the antimalarial agent amodiaquine was studied 
in liver microsomes and recombinant enzymes. Electrochemical oxidation was used to 
characterize metabolic intermediates and enabled the structural determination of an aldehyde 
metabolite of amodiaquine by NMR spectroscopy. In addition, the bioactivation of the 
neuroleptic drug haloperidol was studied. Proposed iminium species of haloperidol were 
observed in the on-line electrochemical oxidation setup. Subsequent trapping with cyanide, 
both in liver microsomes and in the electrochemical system, strengthened the proposal of 
iminium intermediate formation in the oxidative metabolism of haloperidol. Further, in the 
cyanide trapping experiments the presence of the dihydropyridinium species and the absence 
of the corresponding cyano adduct indicated that an unstable cyano adduct was formed. 
Trapping of an exocyclic iminium species with cyanide in the electrochemical experiments 
but not in the liver microsomal incubations implied that this intermediate, obligatory in the 
electrochemically mediated N-dealkylation, may not be formed in the CYP-catalyzed 
reaction.  
Metabolic studies on haloperidol and trifluperidol, in comparison with their corresponding 
silicon analogues, were performed in liver microsomes and hepatocytes. The replacement of 
one single carbon atom by a silicon atom resulted in significant metabolic changes, including 
the absence of silapyridinium metabolites and glucuronidation on the silanol group.  
In conclusion, several different examples of how electrochemistry can be used in studies on 
reactive metabolites are provided in this thesis. For drug risk assessment, it is important to 
characterize formed reactive metabolites and if possible, alter chemical design to avoid 
reactivity.
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